Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Multiplexed mass spectrometry monitoring of biomarker candidates for osteoarthritis

  • Fernández-Puente, Patricia
  • Calamia, Valentina
  • González-Rodríguez, Lucía
  • Lourido, Lucía
  • Camacho Encina, María
  • Oreiro Villar, Natividad
  • Ruiz-Romero, Cristina
  • Blanco García, Francisco J
[Abstract] The methods currently available for the diagnosis and monitoring of osteoarthritis (OA) are very limited and lack sensitivity. Being the most prevalent rheumatic disease, one of the most disabling pathologies worldwide and currently untreatable, there is a considerable interest pointed in the verification of specific biological markers for improving its diagnosis and disease progression studies. Considering the remarkable development of targeted proteomics methodologies in the frame of the Human Proteome Project, the aim of this work was to develop and apply a MRM-based method for the multiplexed analysis of a panel of 6 biomarker candidates for OA encoded by the Chromosome 16, and another 8 proteins identified in previous shotgun studies as related with this pathology, in specimens derived from the human joint and serum. The method, targeting 35 different peptides, was applied to samples from human articular chondrocytes, healthy and osteoarthritic cartilage, synovial fluid and serum. Subsequently, a verification analysis of the biomarker value of these proteins was performed by single point measurements on a set of 116 serum samples, leading to the identification of increased amounts of Haptoglobin and von Willebrand Factor in OA patients. Altogether, the present work provides a tool for the multiplexed monitoring of 14 biomarker candidates for OA, and verifies for the first time the increased amount of two of these circulating markers in patients diagnosed with this disease. Significance: We have developed an MRM method for the identification and relative quantification of a panel of 14 protein biomarker candidates for osteoarthritis. This method has been applied to analyze human articular chondrocytes, articular cartilage, synovial fluid, and finally a collection of 116 serum samples from healthy controls and patients suffering different degrees of osteoarthritis, in order to verify the biomarker usefulness of the candidates. HPT and VWF were validated as increased in OA patients., This work was funded by grants from Fondo Investigación Sanitaria-Spain (PI12/00329, PI14/01707, CIBER-CB06/01/0040, RETIC-RIER-RD12/0009/0018). C.R.-R. is supported by the Miguel Servet II program from Fondo Investigación Sanitaria-Spain (CPII15/00013). The Proteomics Unit belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

MALDI mass spectrometry imaging in rheumatic diseases

  • Rocha Loureda, Beatriz
  • Cillero-Pastor, B.
  • Blanco García, Francisco J
  • Ruiz-Romero, Cristina
Review, [Abstract] Mass spectrometry imaging (MSI) is a technique used to visualize the spatial distribution of biomolecules such as peptides, proteins, lipids or other organic compounds by their molecular masses. Among the different MSI strategies, MALDI-MSI provides a sensitive and label-free approach for imaging of a wide variety of protein or peptide biomarkers from the surface of tissue sections, being currently used in an increasing number of biomedical applications such as biomarker discovery and tissue classification. In the field of rheumatology, MALDI-MSI has been applied to date for the analysis of joint tissues such as synovial membrane or cartilage. This review summarizes the studies and key achievements obtained using MALDI-MSI to increase understanding on rheumatic pathologies and to describe potential diagnostic or prognostic biomarkers of these diseases. This article is part of a Special Issue entitled: MALDI Imaging, edited by Dr. Corinna Henkel and Prof. Peter Hoffmann., This work was funded by grants from Fondo Investigación Sanitaria-Spain (PI12/00329, PI14/01707, CIBER-CB06/01/0040, RETIC-RIER-RD12/0009/0018). C.R.-R. is supported by the Miguel Servet II program from Fondo Investigación Sanitaria-Spain (CPII15/00013). The Proteomics Unit belongs to ProteoRed, PRB2- ISCIII, supported by grant PT13/0001.